These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 12351452

  • 1. Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.
    Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R.
    Diabetes; 2002 Oct; 51(10):3090-4. PubMed ID: 12351452
    [Abstract] [Full Text] [Related]

  • 2. Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice.
    Flyvbjerg A, Denner L, Schrijvers BF, Tilton RG, Mogensen TH, Paludan SR, Rasch R.
    Diabetes; 2004 Jan; 53(1):166-72. PubMed ID: 14693711
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
    Schrijvers BF, De Vriese AS, Tilton RG, Van de Voorde J, Denner L, Lameire NH, Flyvbjerg A.
    Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
    [Abstract] [Full Text] [Related]

  • 4. Renal effects of a neutralising RAGE-antibody in long-term streptozotocin-diabetic mice.
    Jensen LJ, Denner L, Schrijvers BF, Tilton RG, Rasch R, Flyvbjerg A.
    J Endocrinol; 2006 Mar; 188(3):493-501. PubMed ID: 16522729
    [Abstract] [Full Text] [Related]

  • 5. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
    Schrijvers BF, Flyvbjerg A, Tilton RG, Lameire NH, De Vriese AS.
    Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
    [Abstract] [Full Text] [Related]

  • 6. 2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice.
    Ichinose K, Maeshima Y, Yamamoto Y, Kinomura M, Hirokoshi K, Kitayama H, Takazawa Y, Sugiyama H, Yamasaki Y, Agata N, Makino H.
    Diabetes; 2006 May; 55(5):1232-42. PubMed ID: 16644677
    [Abstract] [Full Text] [Related]

  • 7. Urocortin ameliorates diabetic nephropathy in obese db/db mice.
    Li X, Hu J, Zhang R, Sun X, Zhang Q, Guan X, Chen J, Zhu Q, Li S.
    Br J Pharmacol; 2008 Jul; 154(5):1025-34. PubMed ID: 18587447
    [Abstract] [Full Text] [Related]

  • 8. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury.
    Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH.
    Kidney Int; 2004 Jan; 65(1):116-28. PubMed ID: 14675042
    [Abstract] [Full Text] [Related]

  • 9. High protein-induced glomerular hypertrophy is vascular endothelial growth factor-dependent.
    Schrijvers BF, Rasch R, Tilton RG, Flyvbjerg A.
    Kidney Int; 2002 May; 61(5):1600-4. PubMed ID: 11967009
    [Abstract] [Full Text] [Related]

  • 10. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice.
    Ziyadeh FN, Hoffman BB, Han DC, Iglesias-De La Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K.
    Proc Natl Acad Sci U S A; 2000 Jul 05; 97(14):8015-20. PubMed ID: 10859350
    [Abstract] [Full Text] [Related]

  • 11. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes.
    Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH.
    J Am Soc Nephrol; 2001 May 05; 12(5):993-1000. PubMed ID: 11316858
    [Abstract] [Full Text] [Related]

  • 12. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
    Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S.
    Kidney Int; 2002 Sep 05; 62(3):901-13. PubMed ID: 12164872
    [Abstract] [Full Text] [Related]

  • 13. Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.
    Chen S, Iglesias-de la Cruz MC, Jim B, Hong SW, Isono M, Ziyadeh FN.
    Biochem Biophys Res Commun; 2003 Jan 03; 300(1):16-22. PubMed ID: 12480514
    [Abstract] [Full Text] [Related]

  • 14. Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy.
    Cohen MP, Clements RS, Hud E, Cohen JA, Ziyadeh FN.
    Exp Nephrol; 1996 Jan 03; 4(3):166-71. PubMed ID: 8773479
    [Abstract] [Full Text] [Related]

  • 15. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
    Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R.
    FASEB J; 2000 Mar 03; 14(3):439-47. PubMed ID: 10698958
    [Abstract] [Full Text] [Related]

  • 16. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
    Aroor AR, Das NA, Carpenter AJ, Habibi J, Jia G, Ramirez-Perez FI, Martinez-Lemus L, Manrique-Acevedo CM, Hayden MR, Duta C, Nistala R, Mayoux E, Padilla J, Chandrasekar B, DeMarco VG.
    Cardiovasc Diabetol; 2018 Jul 30; 17(1):108. PubMed ID: 30060748
    [Abstract] [Full Text] [Related]

  • 17. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice.
    Sung SH, Ziyadeh FN, Wang A, Pyagay PE, Kanwar YS, Chen S.
    J Am Soc Nephrol; 2006 Nov 30; 17(11):3093-104. PubMed ID: 16988063
    [Abstract] [Full Text] [Related]

  • 18. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.
    Ichinose K, Maeshima Y, Yamamoto Y, Kitayama H, Takazawa Y, Hirokoshi K, Sugiyama H, Yamasaki Y, Eguchi K, Makino H.
    Diabetes; 2005 Oct 30; 54(10):2891-903. PubMed ID: 16186390
    [Abstract] [Full Text] [Related]

  • 19. DBA2J db/db mice are susceptible to early albuminuria and glomerulosclerosis that correlate with systemic insulin resistance.
    Østergaard MV, Pinto V, Stevenson K, Worm J, Fink LN, Coward RJ.
    Am J Physiol Renal Physiol; 2017 Feb 01; 312(2):F312-F321. PubMed ID: 27852608
    [Abstract] [Full Text] [Related]

  • 20. Effect of varied protein intake on the nephropathy of the diabetic mouse (C57BL/s J db/db).
    Brouhard BH, Rajaraman S, LaGrone LF.
    Int J Pediatr Nephrol; 1987 Feb 01; 8(2):59-68. PubMed ID: 3308729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.